Magellan Health (MGLN) Reports Q4 EPS Loss of ($0.77), Revenues Miss; Offers FY19 EPS Mid-Point Guidance Above Consensus, FY19 Revenue Mid-Point Views Below Estimates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Magellan Health Reports Fourth Quarter and Full Year 2018 Financial Results
February 28, 2019 6:30 AM ESTSCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Health, Inc. (NASDAQ: MGLN) today announced financial results for the fourth quarter and full year ended December 31, 2018, as summarized below:
Three Months Ended Years Ended December 31 December 31 (In millions, except per share results)2018
2017
Chg
2018
2017
Chg
Net revenue $ 1,844.6 $ 1,694.4 8.9 % $ 7,314.2 $ 5,838.6 25.3 % Net income (loss) $ (28.0 ) $ 54.5 -151.3 % $ 24.2 $ 110.2... More